Stay updated on Pembrolizumab Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page
- Check7 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No adjustments to study details, eligibility criteria, or results are evident.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.4.3 update applied, replacing v3.4.2. This is a minor version update with no changes to the study information or user-facing features.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 as the page's version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No clinical trial content, eligibility criteria, or outcome measures appear to be altered.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded a Locations section listing Georgia (Atlanta, Emory University/Winship Cancer Institute) as a study site. Removed the previous Georgia Locations heading and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.